Datasets:
registry_id stringlengths 17 17 | year int64 1.99k 2.02k | age int64 0 95 | age_group stringclasses 8
values | sex stringclasses 2
values | cancer_type stringclasses 16
values | morphology stringclasses 8
values | grade stringclasses 5
values | basis_of_diagnosis stringclasses 5
values | residence stringclasses 3
values | vital_status stringclasses 3
values | survival_months float64 0 60 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UG-KLA-2009-00001 | 2,009 | 4 | 0-14 | Male | Oesophagus | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 37.8 | moderate_burden |
UG-KLA-2016-00002 | 2,016 | 43 | 35-44 | Male | Non-Hodgkin lymphoma | Squamous cell carcinoma | Moderately differentiated (Grade II) | Death certificate only | peri-urban | Dead | 14 | moderate_burden |
UG-KLA-2017-00003 | 2,017 | 94 | 75+ | Female | Cervix uteri | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 56 | moderate_burden |
UG-KLA-1993-00004 | 1,993 | 54 | 45-54 | Female | Cervix uteri | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 13.2 | moderate_burden |
UG-KLA-2008-00005 | 2,008 | 63 | 55-64 | Male | Liver | Lymphoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 47.2 | moderate_burden |
UG-KLA-1997-00006 | 1,997 | 65 | 65-74 | Male | Non-Hodgkin lymphoma | Sarcoma (incl. KS) | Undifferentiated (Grade IV) | Imaging + clinical | Rural | Alive | 27 | moderate_burden |
UG-KLA-1991-00007 | 1,991 | 62 | 55-64 | Male | Other | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 42.6 | moderate_burden |
UG-KLA-2010-00008 | 2,010 | 70 | 65-74 | Female | Thyroid | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 12.3 | moderate_burden |
UG-KLA-2014-00009 | 2,014 | 50 | 45-54 | Female | Thyroid | Squamous cell carcinoma | Unknown | Microscopy (histology/cytology) | peri-urban | Alive | 26.8 | moderate_burden |
UG-KLA-2019-00010 | 2,019 | 41 | 35-44 | Female | Thyroid | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Death certificate only | Rural | Alive | 37 | moderate_burden |
UG-KLA-1998-00011 | 1,998 | 73 | 65-74 | Male | Liver | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | peri-urban | Dead | 58.1 | moderate_burden |
UG-KLA-2015-00012 | 2,015 | 54 | 45-54 | Female | Other | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Imaging + clinical | peri-urban | Dead | 5.4 | moderate_burden |
UG-KLA-2016-00013 | 2,016 | 54 | 45-54 | Female | Other | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 0.6 | moderate_burden |
UG-KLA-2014-00014 | 2,014 | 34 | 25-34 | Male | Liver | Sarcoma (incl. KS) | Well differentiated (Grade I) | Microscopy (histology/cytology) | Rural | Dead | 27.5 | moderate_burden |
UG-KLA-1999-00015 | 1,999 | 33 | 25-34 | Female | Other | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 14.3 | moderate_burden |
UG-KLA-2014-00016 | 2,014 | 71 | 65-74 | Female | Other | Unspecified | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Rural | Alive | 60 | moderate_burden |
UG-KLA-1998-00017 | 1,998 | 54 | 45-54 | Male | Kaposi sarcoma | Other specified | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 32.7 | moderate_burden |
UG-KLA-2013-00018 | 2,013 | 38 | 35-44 | Female | Other | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 10.4 | moderate_burden |
UG-KLA-2001-00019 | 2,001 | 58 | 55-64 | Male | Oesophagus | Lymphoma | Unknown | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 60 | moderate_burden |
UG-KLA-2009-00020 | 2,009 | 64 | 55-64 | Female | Cervix uteri | Lymphoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | peri-urban | Dead | 20.4 | moderate_burden |
UG-KLA-2006-00021 | 2,006 | 62 | 55-64 | Male | Non-Hodgkin lymphoma | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 15.1 | moderate_burden |
UG-KLA-2013-00022 | 2,013 | 64 | 55-64 | Female | Cervix uteri | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | peri-urban | Alive | 20.4 | moderate_burden |
UG-KLA-2016-00023 | 2,016 | 47 | 45-54 | Male | Prostate | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 30.6 | moderate_burden |
UG-KLA-2014-00024 | 2,014 | 67 | 65-74 | Female | Cervix uteri | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 19.5 | moderate_burden |
UG-KLA-2006-00025 | 2,006 | 37 | 35-44 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | peri-urban | Dead | 2.3 | moderate_burden |
UG-KLA-1998-00026 | 1,998 | 63 | 55-64 | Female | Cervix uteri | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Rural | Alive | 19 | moderate_burden |
UG-KLA-2017-00027 | 2,017 | 61 | 55-64 | Male | Non-Hodgkin lymphoma | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | peri-urban | Dead | 20.3 | moderate_burden |
UG-KLA-2003-00028 | 2,003 | 36 | 35-44 | Male | Kaposi sarcoma | Sarcoma (incl. KS) | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 4.5 | moderate_burden |
UG-KLA-2005-00029 | 2,005 | 38 | 35-44 | Female | Other | Leukemia | Well differentiated (Grade I) | Microscopy (histology/cytology) | Rural | Dead | 20.6 | moderate_burden |
UG-KLA-2013-00030 | 2,013 | 49 | 45-54 | Female | Thyroid | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Rural | Alive | 4.4 | moderate_burden |
UG-KLA-2009-00031 | 2,009 | 50 | 45-54 | Female | Cervix uteri | Leukemia | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 4.3 | moderate_burden |
UG-KLA-2010-00032 | 2,010 | 72 | 65-74 | Female | Breast | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 25.8 | moderate_burden |
UG-KLA-1999-00033 | 1,999 | 54 | 45-54 | Male | Other | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 60 | moderate_burden |
UG-KLA-1997-00034 | 1,997 | 8 | 0-14 | Female | Breast | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | peri-urban | Dead | 1.3 | moderate_burden |
UG-KLA-2011-00035 | 2,011 | 32 | 25-34 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Clinical only | peri-urban | Alive | 35.5 | moderate_burden |
UG-KLA-2014-00036 | 2,014 | 68 | 65-74 | Female | Breast | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 15.2 | moderate_burden |
UG-KLA-1998-00037 | 1,998 | 42 | 35-44 | Male | Prostate | Adenocarcinoma | Undifferentiated (Grade IV) | Imaging + clinical | Urban (Kampala) | Alive | 60 | moderate_burden |
UG-KLA-1994-00038 | 1,994 | 35 | 35-44 | Female | Other | Adenocarcinoma | Moderately differentiated (Grade II) | Clinical only | Urban (Kampala) | Dead | 0.4 | moderate_burden |
UG-KLA-2018-00039 | 2,018 | 44 | 35-44 | Female | Other | Lymphoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Lost to follow-up | 33.7 | moderate_burden |
UG-KLA-2004-00040 | 2,004 | 63 | 55-64 | Male | Other | Lymphoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 7.7 | moderate_burden |
UG-KLA-1996-00041 | 1,996 | 44 | 35-44 | Female | Breast | Adenocarcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Lost to follow-up | 11 | moderate_burden |
UG-KLA-2006-00042 | 2,006 | 58 | 55-64 | Female | Other | Squamous cell carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | peri-urban | Alive | 11.4 | moderate_burden |
UG-KLA-2006-00043 | 2,006 | 53 | 45-54 | Female | Breast | Adenocarcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 18.8 | moderate_burden |
UG-KLA-2015-00044 | 2,015 | 44 | 35-44 | Female | Cervix uteri | Non-keratinizing carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Lost to follow-up | 52.2 | moderate_burden |
UG-KLA-2003-00045 | 2,003 | 25 | 25-34 | Female | Corpus uteri | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Imaging + clinical | Rural | Alive | 1.1 | moderate_burden |
UG-KLA-2001-00046 | 2,001 | 45 | 45-54 | Male | Hodgkin lymphoma | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 33.8 | moderate_burden |
UG-KLA-2015-00047 | 2,015 | 41 | 35-44 | Female | Cervix uteri | Non-keratinizing carcinoma | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 31.4 | moderate_burden |
UG-KLA-1995-00048 | 1,995 | 50 | 45-54 | Female | Other | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | peri-urban | Alive | 45.8 | moderate_burden |
UG-KLA-2009-00049 | 2,009 | 72 | 65-74 | Female | Corpus uteri | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 9.8 | moderate_burden |
UG-KLA-2009-00050 | 2,009 | 64 | 55-64 | Female | Breast | Squamous cell carcinoma | Undifferentiated (Grade IV) | Imaging + clinical | Urban (Kampala) | Alive | 59.5 | moderate_burden |
UG-KLA-2001-00051 | 2,001 | 55 | 55-64 | Female | Cervix uteri | Squamous cell carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 9.5 | moderate_burden |
UG-KLA-2010-00052 | 2,010 | 38 | 35-44 | Female | Other | Lymphoma | Poorly differentiated (Grade III) | Imaging + clinical | peri-urban | Alive | 26.7 | moderate_burden |
UG-KLA-2008-00053 | 2,008 | 15 | 15-24 | Male | Prostate | Lymphoma | Poorly differentiated (Grade III) | Clinical only | Urban (Kampala) | Lost to follow-up | 4 | moderate_burden |
UG-KLA-2010-00054 | 2,010 | 52 | 45-54 | Male | Liver | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | peri-urban | Alive | 8.9 | moderate_burden |
UG-KLA-2014-00055 | 2,014 | 43 | 35-44 | Male | Other | Sarcoma (incl. KS) | Unknown | Imaging + clinical | Rural | Alive | 21.5 | moderate_burden |
UG-KLA-2016-00056 | 2,016 | 57 | 55-64 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Death certificate only | peri-urban | Alive | 25 | moderate_burden |
UG-KLA-2009-00057 | 2,009 | 38 | 35-44 | Female | Breast | Adenocarcinoma | Well differentiated (Grade I) | Imaging + clinical | peri-urban | Alive | 60 | moderate_burden |
UG-KLA-2003-00058 | 2,003 | 60 | 55-64 | Female | Cervix uteri | Adenocarcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Urban (Kampala) | Alive | 6.4 | moderate_burden |
UG-KLA-2001-00059 | 2,001 | 48 | 45-54 | Male | Prostate | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Clinical only | Urban (Kampala) | Dead | 46.1 | moderate_burden |
UG-KLA-2012-00060 | 2,012 | 55 | 55-64 | Female | Other | Squamous cell carcinoma | Unknown | Clinical only | Urban (Kampala) | Alive | 6.4 | moderate_burden |
UG-KLA-2010-00061 | 2,010 | 48 | 45-54 | Male | Kaposi sarcoma | Adenocarcinoma | Undifferentiated (Grade IV) | Clinical only | Rural | Alive | 2.5 | moderate_burden |
UG-KLA-2010-00062 | 2,010 | 29 | 25-34 | Female | Ovary | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | peri-urban | Alive | 9.6 | moderate_burden |
UG-KLA-2013-00063 | 2,013 | 71 | 65-74 | Male | Leukemia | Sarcoma (incl. KS) | Well differentiated (Grade I) | Microscopy (histology/cytology) | peri-urban | Dead | 3.8 | moderate_burden |
UG-KLA-2016-00064 | 2,016 | 57 | 55-64 | Male | Kaposi sarcoma | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | peri-urban | Alive | 7.1 | moderate_burden |
UG-KLA-1996-00065 | 1,996 | 72 | 65-74 | Female | Cervix uteri | Adenocarcinoma | Moderately differentiated (Grade II) | Imaging + clinical | Urban (Kampala) | Lost to follow-up | 15.6 | moderate_burden |
UG-KLA-2003-00066 | 2,003 | 61 | 55-64 | Female | Cervix uteri | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 5.1 | moderate_burden |
UG-KLA-2009-00067 | 2,009 | 62 | 55-64 | Female | Thyroid | Squamous cell carcinoma | Well differentiated (Grade I) | Imaging + clinical | peri-urban | Alive | 54 | moderate_burden |
UG-KLA-2001-00068 | 2,001 | 26 | 25-34 | Female | Breast | Squamous cell carcinoma | Poorly differentiated (Grade III) | Death certificate only | Urban (Kampala) | Lost to follow-up | 43.2 | moderate_burden |
UG-KLA-2017-00069 | 2,017 | 58 | 55-64 | Female | Cervix uteri | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 25.1 | moderate_burden |
UG-KLA-2003-00070 | 2,003 | 62 | 55-64 | Female | Other | Unspecified | Undifferentiated (Grade IV) | Other | Urban (Kampala) | Dead | 7.8 | moderate_burden |
UG-KLA-2007-00071 | 2,007 | 73 | 65-74 | Female | Breast | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 13.4 | moderate_burden |
UG-KLA-2001-00072 | 2,001 | 48 | 45-54 | Male | Prostate | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 31.3 | moderate_burden |
UG-KLA-2014-00073 | 2,014 | 70 | 65-74 | Male | Kaposi sarcoma | Leukemia | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 8.3 | moderate_burden |
UG-KLA-2003-00074 | 2,003 | 59 | 55-64 | Female | Breast | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | peri-urban | Dead | 7 | moderate_burden |
UG-KLA-1999-00075 | 1,999 | 43 | 35-44 | Female | Cervix uteri | Sarcoma (incl. KS) | Well differentiated (Grade I) | Microscopy (histology/cytology) | peri-urban | Lost to follow-up | 55.7 | moderate_burden |
UG-KLA-1999-00076 | 1,999 | 31 | 25-34 | Female | Cervix uteri | Lymphoma | Moderately differentiated (Grade II) | Imaging + clinical | peri-urban | Dead | 13.1 | moderate_burden |
UG-KLA-2001-00077 | 2,001 | 57 | 55-64 | Male | Other | Adenocarcinoma | Undifferentiated (Grade IV) | Clinical only | Rural | Dead | 8.4 | moderate_burden |
UG-KLA-2007-00078 | 2,007 | 43 | 35-44 | Female | Other | Squamous cell carcinoma | Moderately differentiated (Grade II) | Other | Urban (Kampala) | Alive | 24.3 | moderate_burden |
UG-KLA-2001-00079 | 2,001 | 61 | 55-64 | Male | Kaposi sarcoma | Sarcoma (incl. KS) | Unknown | Death certificate only | peri-urban | Alive | 60 | moderate_burden |
UG-KLA-2004-00080 | 2,004 | 18 | 15-24 | Male | Prostate | Squamous cell carcinoma | Well differentiated (Grade I) | Death certificate only | Rural | Alive | 15.2 | moderate_burden |
UG-KLA-2011-00081 | 2,011 | 48 | 45-54 | Male | Other | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 2.3 | moderate_burden |
UG-KLA-1999-00082 | 1,999 | 42 | 35-44 | Female | Cervix uteri | Sarcoma (incl. KS) | Well differentiated (Grade I) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 2.8 | moderate_burden |
UG-KLA-2005-00083 | 2,005 | 4 | 0-14 | Female | Breast | Lymphoma | Poorly differentiated (Grade III) | Death certificate only | Urban (Kampala) | Alive | 11.7 | moderate_burden |
UG-KLA-2014-00084 | 2,014 | 48 | 45-54 | Female | Breast | Sarcoma (incl. KS) | Well differentiated (Grade I) | Microscopy (histology/cytology) | Rural | Dead | 1.6 | moderate_burden |
UG-KLA-2008-00085 | 2,008 | 52 | 45-54 | Male | Stomach | Sarcoma (incl. KS) | Moderately differentiated (Grade II) | Death certificate only | peri-urban | Alive | 22.4 | moderate_burden |
UG-KLA-2016-00086 | 2,016 | 71 | 65-74 | Male | Other | Sarcoma (incl. KS) | Unknown | Microscopy (histology/cytology) | peri-urban | Alive | 33.5 | moderate_burden |
UG-KLA-2014-00087 | 2,014 | 71 | 65-74 | Male | Non-Hodgkin lymphoma | Squamous cell carcinoma | Moderately differentiated (Grade II) | Imaging + clinical | Urban (Kampala) | Alive | 1.8 | moderate_burden |
UG-KLA-2005-00088 | 2,005 | 20 | 15-24 | Female | Corpus uteri | Non-keratinizing carcinoma | Moderately differentiated (Grade II) | Clinical only | Urban (Kampala) | Alive | 16.2 | moderate_burden |
UG-KLA-2010-00089 | 2,010 | 60 | 55-64 | Female | Other | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Clinical only | Urban (Kampala) | Alive | 0.4 | moderate_burden |
UG-KLA-1997-00090 | 1,997 | 45 | 45-54 | Female | Cervix uteri | Adenocarcinoma | Poorly differentiated (Grade III) | Imaging + clinical | Urban (Kampala) | Dead | 50.5 | moderate_burden |
UG-KLA-1992-00091 | 1,992 | 72 | 65-74 | Female | Cervix uteri | Adenocarcinoma | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Rural | Alive | 2.9 | moderate_burden |
UG-KLA-2010-00092 | 2,010 | 94 | 75+ | Female | Cervix uteri | Squamous cell carcinoma | Moderately differentiated (Grade II) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 18.6 | moderate_burden |
UG-KLA-2004-00093 | 2,004 | 23 | 15-24 | Female | Thyroid | Lymphoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 18.4 | moderate_burden |
UG-KLA-1995-00094 | 1,995 | 61 | 55-64 | Female | Breast | Non-keratinizing carcinoma | Poorly differentiated (Grade III) | Imaging + clinical | peri-urban | Alive | 6 | moderate_burden |
UG-KLA-2002-00095 | 2,002 | 86 | 75+ | Female | Other | Squamous cell carcinoma | Unknown | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 40.6 | moderate_burden |
UG-KLA-1995-00096 | 1,995 | 52 | 45-54 | Female | Cervix uteri | Lymphoma | Undifferentiated (Grade IV) | Clinical only | Urban (Kampala) | Dead | 23.5 | moderate_burden |
UG-KLA-2000-00097 | 2,000 | 19 | 15-24 | Male | Other | Adenocarcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | peri-urban | Alive | 46.3 | moderate_burden |
UG-KLA-1999-00098 | 1,999 | 12 | 0-14 | Female | Breast | Squamous cell carcinoma | Unknown | Clinical only | Urban (Kampala) | Dead | 15.5 | moderate_burden |
UG-KLA-2004-00099 | 2,004 | 74 | 65-74 | Female | Thyroid | Sarcoma (incl. KS) | Poorly differentiated (Grade III) | Microscopy (histology/cytology) | Urban (Kampala) | Dead | 4.6 | moderate_burden |
UG-KLA-1991-00100 | 1,991 | 27 | 25-34 | Female | Breast | Squamous cell carcinoma | Undifferentiated (Grade IV) | Microscopy (histology/cytology) | Urban (Kampala) | Alive | 31.3 | moderate_burden |
⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference.
Uganda Cancer Registry - Kampala
Abstract
This synthetic dataset represents population-based cancer registry data for kampala and is designed to address the significant data gap in cancer research for sub-Saharan Africa. The dataset contains 3,200-4,800 per scenario records per scenario with key epidemiological parameters grounded in GLOBOCAN 2022 estimates, WHO reports, and peer-reviewed literature from the African Cancer Registry Network (AFCRN).
The age-standardized incidence rate (ASIR) of Uganda Cancer Registry in the target population is approximately 104.5 per 100,000 population (GLOBOCAN 2022). This dataset provides training data for cancer epidemiology modeling, health systems research, and machine learning applications in oncology.
1. Introduction
1.1 Problem Statement
Cancer incidence in sub-Saharan Africa is rising rapidly, with estimated new cases reaching over 1 million annually by 2030. However, the region faces a critical shortage of granular cancer data for research, policy development, and health system planning. Population-based cancer registries cover less than 5% of the African population, creating significant gaps in understanding the true burden of disease.
1.2 Data Gap
- Limited population-based registry data outside major cities
- Missing survival and outcome data from most facilities
- Underrepresentation of pediatric and rare cancers
- Lack of treatment access and outcome metrics
1.3 Purpose
This dataset supports:
- Cancer burden estimation and projection modeling
- Health system capacity planning
- Machine learning for risk prediction and triage
- Epidemiological research on cancer patterns
- Policy development for cancer control programs
2. Methodology
2.1 Target Population
- Geographic scope: Uganda
- Population represented: Urban and rural populations
- Time period: Variable by data source (2010-2025)
2.2 Variable Selection
Variables were selected based on:
- IARC/WHO cancer registry standards
- Data availability in African cancer registries
- Clinical relevance for cancer control
2.3 Epidemiological Parameterization
All parameters are derived from:
- GLOBOCAN 2022 (IARC)
- WHO Cancer Reports
- African Cancer Registry Network (AFCRN)
- DHS/MICS survey data
- Peer-reviewed literature
2.4 Scenario Design
| Scenario | Description | Records |
|---|---|---|
| low_burden | Low cancer burden setting | Varies by dataset |
| moderate_burden | Standard burden setting | Varies by dataset |
| high_burden | High burden / late presentation | Varies by dataset |
2.5 Generation Process
Generation follows a conditional sampling approach based on directed acyclic graphs (DAGs) representing causal relationships between variables:
- Sample demographic variables (age, sex, location)
- Sample cancer type conditional on demographics
- Sample clinical variables (stage, morphology, grade)
- Sample treatment and outcome variables
- Derive survival times from outcome models
3. Dataset Description
3.1 Key Variables
Population-based cancer registry data for Kampala
3.2 Data Quality
- All categorical distributions validated against published literature
- Continuous variables modeled with appropriate statistical distributions
- Survival times based on exponential models with literature-derived parameters
4. Validation
4.1 Prevalence Verification
All prevalence values are validated against GLOBOCAN 2022 and published registry reports.
4.2 Distribution Quality
- Age and sex distributions match expected patterns
- Cancer type frequencies align with regional estimates
4.3 Clinical Plausibility
- No biologically impossible combinations
- Treatment patterns consistent with resource-limited settings
5. Usage
5.1 Loading with HuggingFace
from datasets import load_dataset
ds = load_dataset("electricsheepafrica/uganda-cancer-kampala", "moderate_burden")
5.2 Loading from CSV
import pandas as pd
df = pd.read_csv("uganda_cancer_kampala_moderate_burden.csv")
6. Limitations
- Synthetic data: Generated from aggregated statistics, not individual patient records
- Simplified correlations: May not capture complex dependencies
- Not for clinical use: Designed for research and ML training only
7. References
- GLOBOCAN 2022. IARC Cancer Observatory.
- African Cancer Registry Network (AFCRN).
- WHO Cancer Control Reports.
- DHS/MICS Survey Data.
Citation
@dataset{uganda_cancer_kampala,
title={Uganda Cancer Registry - Kampala},
author={Electric Sheep Africa},
year={2025},
publisher={HuggingFace},
dataset_url={https://huggingface.co/datasets/electricsheepafrica/uganda-cancer-kampala}
}
License
CC-BY-4.0
- Downloads last month
- 54